The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Rare Biomarkers Market Research Report 2025
Synopsis
The global Rare Biomarkers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Rare Biomarkers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rare Biomarkers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Rare Biomarkers in Diagnostics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Rare Biomarkers include Roche, Thermo Fisher Scientific, Abbott, Qiagen, PerkinElmer, Merck KGaA, Bio-Rad Laboratories, Enzo Biochem, Charles River Laboratories International, Eurofins Scientific, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rare Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rare Biomarkers.
The Rare Biomarkers market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rare Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rare Biomarkers companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Thermo Fisher Scientific
Abbott
Qiagen
PerkinElmer
Merck KGaA
Bio-Rad Laboratories
Enzo Biochem
Charles River Laboratories International
Eurofins Scientific
Agilent Technologies
Bruker
Siemens Healthineers
Epigenomics
GE HealthCare
Diaceutics
Segment by Type
Circulating Cell Free DNA (ccfDNA)
Circulating Tumor Cells (CTCs)
Exosomes/Extracellular Vesicles
Circulating Cell Free RNA (ccfRNA) / miRNA
Segment by Application
Diagnostics
Drug Development
Disease Discovery
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rare Biomarkers company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Rare Biomarkers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Rare Biomarkers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rare Biomarkers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Rare Biomarkers in Diagnostics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Rare Biomarkers include Roche, Thermo Fisher Scientific, Abbott, Qiagen, PerkinElmer, Merck KGaA, Bio-Rad Laboratories, Enzo Biochem, Charles River Laboratories International, Eurofins Scientific, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rare Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rare Biomarkers.
The Rare Biomarkers market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rare Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rare Biomarkers companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Thermo Fisher Scientific
Abbott
Qiagen
PerkinElmer
Merck KGaA
Bio-Rad Laboratories
Enzo Biochem
Charles River Laboratories International
Eurofins Scientific
Agilent Technologies
Bruker
Siemens Healthineers
Epigenomics
GE HealthCare
Diaceutics
Segment by Type
Circulating Cell Free DNA (ccfDNA)
Circulating Tumor Cells (CTCs)
Exosomes/Extracellular Vesicles
Circulating Cell Free RNA (ccfRNA) / miRNA
Segment by Application
Diagnostics
Drug Development
Disease Discovery
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rare Biomarkers company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Biomarkers Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Circulating Cell Free DNA (ccfDNA)
1.2.3 Circulating Tumor Cells (CTCs)
1.2.4 Exosomes/Extracellular Vesicles
1.2.5 Circulating Cell Free RNA (ccfRNA) / miRNA
1.3 Market by Application
1.3.1 Global Rare Biomarkers Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostics
1.3.3 Drug Development
1.3.4 Disease Discovery
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rare Biomarkers Market Perspective (2019-2030)
2.2 Global Rare Biomarkers Growth Trends by Region
2.2.1 Global Rare Biomarkers Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Rare Biomarkers Historic Market Size by Region (2019-2024)
2.2.3 Rare Biomarkers Forecasted Market Size by Region (2025-2030)
2.3 Rare Biomarkers Market Dynamics
2.3.1 Rare Biomarkers Industry Trends
2.3.2 Rare Biomarkers Market Drivers
2.3.3 Rare Biomarkers Market Challenges
2.3.4 Rare Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rare Biomarkers Players by Revenue
3.1.1 Global Top Rare Biomarkers Players by Revenue (2019-2024)
3.1.2 Global Rare Biomarkers Revenue Market Share by Players (2019-2024)
3.2 Global Rare Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Rare Biomarkers Revenue
3.4 Global Rare Biomarkers Market Concentration Ratio
3.4.1 Global Rare Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Biomarkers Revenue in 2023
3.5 Global Key Players of Rare Biomarkers Head office and Area Served
3.6 Global Key Players of Rare Biomarkers, Product and Application
3.7 Global Key Players of Rare Biomarkers, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Rare Biomarkers Breakdown Data by Type
4.1 Global Rare Biomarkers Historic Market Size by Type (2019-2024)
4.2 Global Rare Biomarkers Forecasted Market Size by Type (2025-2030)
5 Rare Biomarkers Breakdown Data by Application
5.1 Global Rare Biomarkers Historic Market Size by Application (2019-2024)
5.2 Global Rare Biomarkers Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Rare Biomarkers Market Size (2019-2030)
6.2 North America Rare Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Rare Biomarkers Market Size by Country (2019-2024)
6.4 North America Rare Biomarkers Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rare Biomarkers Market Size (2019-2030)
7.2 Europe Rare Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Rare Biomarkers Market Size by Country (2019-2024)
7.4 Europe Rare Biomarkers Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rare Biomarkers Market Size (2019-2030)
8.2 Asia-Pacific Rare Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Rare Biomarkers Market Size by Region (2019-2024)
8.4 Asia-Pacific Rare Biomarkers Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rare Biomarkers Market Size (2019-2030)
9.2 Latin America Rare Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Rare Biomarkers Market Size by Country (2019-2024)
9.4 Latin America Rare Biomarkers Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rare Biomarkers Market Size (2019-2030)
10.2 Middle East & Africa Rare Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Rare Biomarkers Market Size by Country (2019-2024)
10.4 Middle East & Africa Rare Biomarkers Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Rare Biomarkers Introduction
11.1.4 Roche Revenue in Rare Biomarkers Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Rare Biomarkers Introduction
11.2.4 Thermo Fisher Scientific Revenue in Rare Biomarkers Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Rare Biomarkers Introduction
11.3.4 Abbott Revenue in Rare Biomarkers Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Details
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Rare Biomarkers Introduction
11.4.4 Qiagen Revenue in Rare Biomarkers Business (2019-2024)
11.4.5 Qiagen Recent Development
11.5 PerkinElmer
11.5.1 PerkinElmer Company Details
11.5.2 PerkinElmer Business Overview
11.5.3 PerkinElmer Rare Biomarkers Introduction
11.5.4 PerkinElmer Revenue in Rare Biomarkers Business (2019-2024)
11.5.5 PerkinElmer Recent Development
11.6 Merck KGaA
11.6.1 Merck KGaA Company Details
11.6.2 Merck KGaA Business Overview
11.6.3 Merck KGaA Rare Biomarkers Introduction
11.6.4 Merck KGaA Revenue in Rare Biomarkers Business (2019-2024)
11.6.5 Merck KGaA Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Rare Biomarkers Introduction
11.7.4 Bio-Rad Laboratories Revenue in Rare Biomarkers Business (2019-2024)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Enzo Biochem
11.8.1 Enzo Biochem Company Details
11.8.2 Enzo Biochem Business Overview
11.8.3 Enzo Biochem Rare Biomarkers Introduction
11.8.4 Enzo Biochem Revenue in Rare Biomarkers Business (2019-2024)
11.8.5 Enzo Biochem Recent Development
11.9 Charles River Laboratories International
11.9.1 Charles River Laboratories International Company Details
11.9.2 Charles River Laboratories International Business Overview
11.9.3 Charles River Laboratories International Rare Biomarkers Introduction
11.9.4 Charles River Laboratories International Revenue in Rare Biomarkers Business (2019-2024)
11.9.5 Charles River Laboratories International Recent Development
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Company Details
11.10.2 Eurofins Scientific Business Overview
11.10.3 Eurofins Scientific Rare Biomarkers Introduction
11.10.4 Eurofins Scientific Revenue in Rare Biomarkers Business (2019-2024)
11.10.5 Eurofins Scientific Recent Development
11.11 Agilent Technologies
11.11.1 Agilent Technologies Company Details
11.11.2 Agilent Technologies Business Overview
11.11.3 Agilent Technologies Rare Biomarkers Introduction
11.11.4 Agilent Technologies Revenue in Rare Biomarkers Business (2019-2024)
11.11.5 Agilent Technologies Recent Development
11.12 Bruker
11.12.1 Bruker Company Details
11.12.2 Bruker Business Overview
11.12.3 Bruker Rare Biomarkers Introduction
11.12.4 Bruker Revenue in Rare Biomarkers Business (2019-2024)
11.12.5 Bruker Recent Development
11.13 Siemens Healthineers
11.13.1 Siemens Healthineers Company Details
11.13.2 Siemens Healthineers Business Overview
11.13.3 Siemens Healthineers Rare Biomarkers Introduction
11.13.4 Siemens Healthineers Revenue in Rare Biomarkers Business (2019-2024)
11.13.5 Siemens Healthineers Recent Development
11.14 Epigenomics
11.14.1 Epigenomics Company Details
11.14.2 Epigenomics Business Overview
11.14.3 Epigenomics Rare Biomarkers Introduction
11.14.4 Epigenomics Revenue in Rare Biomarkers Business (2019-2024)
11.14.5 Epigenomics Recent Development
11.15 GE HealthCare
11.15.1 GE HealthCare Company Details
11.15.2 GE HealthCare Business Overview
11.15.3 GE HealthCare Rare Biomarkers Introduction
11.15.4 GE HealthCare Revenue in Rare Biomarkers Business (2019-2024)
11.15.5 GE HealthCare Recent Development
11.16 Diaceutics
11.16.1 Diaceutics Company Details
11.16.2 Diaceutics Business Overview
11.16.3 Diaceutics Rare Biomarkers Introduction
11.16.4 Diaceutics Revenue in Rare Biomarkers Business (2019-2024)
11.16.5 Diaceutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Rare Biomarkers Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Circulating Cell Free DNA (ccfDNA)
Table 3. Key Players of Circulating Tumor Cells (CTCs)
Table 4. Key Players of Exosomes/Extracellular Vesicles
Table 5. Key Players of Circulating Cell Free RNA (ccfRNA) / miRNA
Table 6. Global Rare Biomarkers Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Rare Biomarkers Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Rare Biomarkers Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Rare Biomarkers Market Share by Region (2019-2024)
Table 10. Global Rare Biomarkers Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Rare Biomarkers Market Share by Region (2025-2030)
Table 12. Rare Biomarkers Market Trends
Table 13. Rare Biomarkers Market Drivers
Table 14. Rare Biomarkers Market Challenges
Table 15. Rare Biomarkers Market Restraints
Table 16. Global Rare Biomarkers Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Rare Biomarkers Market Share by Players (2019-2024)
Table 18. Global Top Rare Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Biomarkers as of 2023)
Table 19. Ranking of Global Top Rare Biomarkers Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Rare Biomarkers Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Rare Biomarkers, Headquarters and Area Served
Table 22. Global Key Players of Rare Biomarkers, Product and Application
Table 23. Global Key Players of Rare Biomarkers, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Rare Biomarkers Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Rare Biomarkers Revenue Market Share by Type (2019-2024)
Table 27. Global Rare Biomarkers Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Rare Biomarkers Revenue Market Share by Type (2025-2030)
Table 29. Global Rare Biomarkers Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Rare Biomarkers Revenue Market Share by Application (2019-2024)
Table 31. Global Rare Biomarkers Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Rare Biomarkers Revenue Market Share by Application (2025-2030)
Table 33. North America Rare Biomarkers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Rare Biomarkers Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Rare Biomarkers Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Rare Biomarkers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Rare Biomarkers Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Rare Biomarkers Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Rare Biomarkers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Rare Biomarkers Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Rare Biomarkers Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Rare Biomarkers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Rare Biomarkers Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Rare Biomarkers Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Rare Biomarkers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Rare Biomarkers Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Rare Biomarkers Market Size by Country (2025-2030) & (US$ Million)
Table 48. Roche Company Details
Table 49. Roche Business Overview
Table 50. Roche Rare Biomarkers Product
Table 51. Roche Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)
Table 52. Roche Recent Development
Table 53. Thermo Fisher Scientific Company Details
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific Rare Biomarkers Product
Table 56. Thermo Fisher Scientific Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)
Table 57. Thermo Fisher Scientific Recent Development
Table 58. Abbott Company Details
Table 59. Abbott Business Overview
Table 60. Abbott Rare Biomarkers Product
Table 61. Abbott Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)
Table 62. Abbott Recent Development
Table 63. Qiagen Company Details
Table 64. Qiagen Business Overview
Table 65. Qiagen Rare Biomarkers Product
Table 66. Qiagen Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)
Table 67. Qiagen Recent Development
Table 68. PerkinElmer Company Details
Table 69. PerkinElmer Business Overview
Table 70. PerkinElmer Rare Biomarkers Product
Table 71. PerkinElmer Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)
Table 72. PerkinElmer Recent Development
Table 73. Merck KGaA Company Details
Table 74. Merck KGaA Business Overview
Table 75. Merck KGaA Rare Biomarkers Product
Table 76. Merck KGaA Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)
Table 77. Merck KGaA Recent Development
Table 78. Bio-Rad Laboratories Company Details
Table 79. Bio-Rad Laboratories Business Overview
Table 80. Bio-Rad Laboratories Rare Biomarkers Product
Table 81. Bio-Rad Laboratories Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)
Table 82. Bio-Rad Laboratories Recent Development
Table 83. Enzo Biochem Company Details
Table 84. Enzo Biochem Business Overview
Table 85. Enzo Biochem Rare Biomarkers Product
Table 86. Enzo Biochem Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)
Table 87. Enzo Biochem Recent Development
Table 88. Charles River Laboratories International Company Details
Table 89. Charles River Laboratories International Business Overview
Table 90. Charles River Laboratories International Rare Biomarkers Product
Table 91. Charles River Laboratories International Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)
Table 92. Charles River Laboratories International Recent Development
Table 93. Eurofins Scientific Company Details
Table 94. Eurofins Scientific Business Overview
Table 95. Eurofins Scientific Rare Biomarkers Product
Table 96. Eurofins Scientific Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)
Table 97. Eurofins Scientific Recent Development
Table 98. Agilent Technologies Company Details
Table 99. Agilent Technologies Business Overview
Table 100. Agilent Technologies Rare Biomarkers Product
Table 101. Agilent Technologies Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)
Table 102. Agilent Technologies Recent Development
Table 103. Bruker Company Details
Table 104. Bruker Business Overview
Table 105. Bruker Rare Biomarkers Product
Table 106. Bruker Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)
Table 107. Bruker Recent Development
Table 108. Siemens Healthineers Company Details
Table 109. Siemens Healthineers Business Overview
Table 110. Siemens Healthineers Rare Biomarkers Product
Table 111. Siemens Healthineers Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)
Table 112. Siemens Healthineers Recent Development
Table 113. Epigenomics Company Details
Table 114. Epigenomics Business Overview
Table 115. Epigenomics Rare Biomarkers Product
Table 116. Epigenomics Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)
Table 117. Epigenomics Recent Development
Table 118. GE HealthCare Company Details
Table 119. GE HealthCare Business Overview
Table 120. GE HealthCare Rare Biomarkers Product
Table 121. GE HealthCare Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)
Table 122. GE HealthCare Recent Development
Table 123. Diaceutics Company Details
Table 124. Diaceutics Business Overview
Table 125. Diaceutics Rare Biomarkers Product
Table 126. Diaceutics Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)
Table 127. Diaceutics Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Rare Biomarkers Picture
Figure 2. Global Rare Biomarkers Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Rare Biomarkers Market Share by Type: 2023 VS 2030
Figure 4. Circulating Cell Free DNA (ccfDNA) Features
Figure 5. Circulating Tumor Cells (CTCs) Features
Figure 6. Exosomes/Extracellular Vesicles Features
Figure 7. Circulating Cell Free RNA (ccfRNA) / miRNA Features
Figure 8. Global Rare Biomarkers Market Size by Application (2024-2030) & (US$ Million)
Figure 9. Global Rare Biomarkers Market Share by Application: 2023 VS 2030
Figure 10. Diagnostics Case Studies
Figure 11. Drug Development Case Studies
Figure 12. Disease Discovery Case Studies
Figure 13. Other Case Studies
Figure 14. Rare Biomarkers Report Years Considered
Figure 15. Global Rare Biomarkers Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Rare Biomarkers Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Rare Biomarkers Market Share by Region: 2023 VS 2030
Figure 18. Global Rare Biomarkers Market Share by Players in 2023
Figure 19. Global Top Rare Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Biomarkers as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Rare Biomarkers Revenue in 2023
Figure 21. North America Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Rare Biomarkers Market Share by Country (2019-2030)
Figure 23. United States Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Rare Biomarkers Market Share by Country (2019-2030)
Figure 27. Germany Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Rare Biomarkers Market Share by Region (2019-2030)
Figure 35. China Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Rare Biomarkers Market Share by Country (2019-2030)
Figure 43. Mexico Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Rare Biomarkers Market Share by Country (2019-2030)
Figure 47. Turkey Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. UAE Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Roche Revenue Growth Rate in Rare Biomarkers Business (2019-2024)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Rare Biomarkers Business (2019-2024)
Figure 52. Abbott Revenue Growth Rate in Rare Biomarkers Business (2019-2024)
Figure 53. Qiagen Revenue Growth Rate in Rare Biomarkers Business (2019-2024)
Figure 54. PerkinElmer Revenue Growth Rate in Rare Biomarkers Business (2019-2024)
Figure 55. Merck KGaA Revenue Growth Rate in Rare Biomarkers Business (2019-2024)
Figure 56. Bio-Rad Laboratories Revenue Growth Rate in Rare Biomarkers Business (2019-2024)
Figure 57. Enzo Biochem Revenue Growth Rate in Rare Biomarkers Business (2019-2024)
Figure 58. Charles River Laboratories International Revenue Growth Rate in Rare Biomarkers Business (2019-2024)
Figure 59. Eurofins Scientific Revenue Growth Rate in Rare Biomarkers Business (2019-2024)
Figure 60. Agilent Technologies Revenue Growth Rate in Rare Biomarkers Business (2019-2024)
Figure 61. Bruker Revenue Growth Rate in Rare Biomarkers Business (2019-2024)
Figure 62. Siemens Healthineers Revenue Growth Rate in Rare Biomarkers Business (2019-2024)
Figure 63. Epigenomics Revenue Growth Rate in Rare Biomarkers Business (2019-2024)
Figure 64. GE HealthCare Revenue Growth Rate in Rare Biomarkers Business (2019-2024)
Figure 65. Diaceutics Revenue Growth Rate in Rare Biomarkers Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
